Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset
β Scribed by Fine, Alan; Reynolds, Gavin P.; Nakajima, Nobue; Jenner, Peter; Marsden, C.David
- Book ID
- 122753941
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 254 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0304-3940
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with LβDOPA and also occur in several nonhuman primate species after 1βmethylβ4βphenylβ1,2,3,6βtetrahydropyridine (MPTP) and LβDOPA treatment. The common marmoset (__Callithrix jacchus__) shows pa
The D2 dopamine agonist piribedil is not widely used in the treatment of Parkinson's disease because it was thought to be effective mainly on parkinsonian tremor and to produce a high incidence of peripheral side effects, particular nausea. In this study, we used 1-methyl-4-phenyl-1,2,3,6-tetrahydro